ACCUBOOST BREAST CANCER TREATMENT


Accuboost at FROS Radiation Oncology Cyberknife Center for Image Guided Breast Irradiation


A new option when making an important decision…

Women with early stage breast cancer increasingly choose to treat the cancer and save their breast. Breast conservation therapy (BCT) starts with the surgical removal of cancerous tissue in a procedure known as lumpectomy. Lumpectomy is followed by daily sessions of radiation therapy to the whole breast for six weeks. Whole breast irradiation (WBI) is widely accepted as the “gold standard” for breast radiotherapy based on over three decades of experience. The BCT protocol also requires additional localized radiation, known as the “boost” dose, aimed only at the tissue surrounding the tumor bed. The combination of surgery and completion of radiation therapy has been effective in preventing cancer recurrence. Numerous studies show that women with early stage disease have a clear option to preserve the breast and fight off the cancer.

The Importance of the Boost Dose
The full course of radiation therapy includes a “boost” dose solely for the breast tissue around the surgical site. This tissue is believed to contain pre-cancerous cells that, if left alone, may cause cancer to return. Numerous studies have shown the contribution of this all-important boost dose for preventing recurrence.
The Need for Boost Dose Improvements
Today, the boost dose is aimed at the surgical site mainly by using the surgical scar left on the skin. It is well known that the incision site is primarily chosen to minimize the visibility of the surgical scar and in most cases does not provide a good reference point for the location of the lumpectomy, and is unrelated to its shape and size. In fact, recent reports indicate that in more than 50% of cases analyzed, the boost dose which is aimed via the surgical scar, misses the intended target. Clearly, methods that direct the boost dose to the target tissue and control both the delivery process and dose quality are important in preventing breast cancer recurrence.
AccuBoost’s Strive for Perfection...
AccuBoost is the latest innovation in breast radiotherapy that achieves the goal of targeting the boost dose to the lumpectomy cavity margin – the tissue that is the most likely site of future recurrence. The AccuBoost design combines a non-invasive method of delivering a well focused beam with the power of real-time image guidance to target the radiation dose accurately and reliably to the surgical excision site (target tissue). Additionally, AccuBoost controls unintentional exposure to otherwise healthy tissue and minimizes radiation-related side effects.
AccuBoost Achieves Results
AccuBoost is the latest innovation in breast radiotherapy that achieves the goal of targeting the boost dose to the lumpectomy cavity margin – the tissue that is the most likely site of future recurrence. The AccuBoost design combines a non-invasive method of delivering a well focused beam with the power of real-time image guidance to target the radiation dose accurately and reliably to the surgical excision site (target tissue). Additionally, AccuBoost controls unintentional exposure to otherwise healthy tissue and minimizes radiation-related side effects.
Hitting the Bull’s Eye – The Importance of IGRT
In the AccuBoost design, the radiographic imaging equipment and the radiation delivery hardware share a common platform making dose targeting accurate and eliminating daily patient positioning “guess-work”. The real-time image guided radiation therapy (IGRT) feature of AccuBoost allows exact targeting of the tissue giving rise to the AccuBoost slogan:
"You see what you treat and you treat what you see"

Accuboost

At FROS Radiation Oncology Cyberknife Center, our team is committed to bringing leading-edge technology with highly compassionate care to our patients.

Please call us at 1-888-880-6646 today to find the right treatment for you.

IN THE NEWS

August 28, 2013

June 1, 2013

FROS attending physicians, Alan Katz and Josephine Kang, to give an oral presentation at this year's ASTRO meeting on long term outcomes after stereotactic body radiation therapy (SBRT) for prostate cancer.

VIDEOS

The Redefining Radiosurgery Video gives definitive clinical, hospital and patient benefits as compared to other radiation therapy and systems.

Contribute!

LOCATIONS

Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
Manhattan: 47 Essex St.
New York, NY 10002

STAY CONNECTED

Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.